Database

Time span

Search terms

The Cochrane Hepato‐Biliary Group Controlled Trials Register

Will be provided at review stage.

(aminoglycoside* or neomycin or neo‐fradin or neo‐tab or mycifradin or myciguent or paromomycin or humatin) AND (metronidazol* or elyzol or flagyl* or rozex or zidoval or metro* or protostat or noritate) AND (encephalopath* or fibro* or cirrho*)

Cochrane Central Register of Controlled Trials (CENTRAL) in the Cochrane Library

Latest issue.

#1 MeSH descriptor: [Aminoglycosides] explode all trees

#2 (aminoglycoside* or neomycin or neo‐fradin or neo‐tab or mycifradin or myciguent or paromomycin or humatin)

#3 (#1 or #2)

#4 MeSH descriptor: [Metronidazole] explode all trees

#5 metronidazol* or elyzol or flagyl* or rozex or zidoval or metro* or protostat or noritate

#6 (#4 or #5)

#7 MeSH descriptor: [Hepatic Encephalopathy] explode all trees

#8 MeSH descriptor: [Fibrosis] explode all trees

#9 MeSH descriptor: [Liver Cirrhosis] explode all trees

#10 encephalopath* or fibro* or cirrho*

#11 (#7 or #8 or #9 or #10)

#12 (#3 and #6 and #11)

MEDLINE Ovid

From 1946 to date of search.

#1 exp Aminoglycosides/

#2 (aminoglycoside* or neomycin or neo‐fradin or neo‐tab or mycifradin or myciguent or paromomycin or humatin).mp. [mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier]

#3 (#1 or #2)

#4 exp Metronidazole/

#5 (metronidazol* or elyzol or flagyl* or rozex or zidoval or metro* or protostat or noritate).mp. [mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier]

#6 (#4 or #5)

#7 exp Hepatic Encephalopathy/

#8 exp Fibrosis/

#9 exp Liver Cirrhosis/

#10 (encephalopath* or fibro* or cirrho*).mp. [mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier]

#11 (#7 or #8 or #9 or #10)

#12 (#3 and #6 and #11)

Embase Ovid

From 1974 to date of search.

#1 exp aminoglycoside/

#2 (aminoglycoside* or neomycin or neo‐fradin or neo‐tab or mycifradin or myciguent or paromomycin or humatin).mp. [mp=title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword, floating subheading]

#3 (#1 or #2)

#4 exp metronidazole/

#5 (metronidazol* or elyzol or flagyl* or rozex or zidoval or metro* or protostat or noritate).mp. [mp=title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword, floating subheading]

#6 (#4 or #5)

#7 exp hepatic encephalopathy/

#8 exp liver fibrosis/

#9 exp liver cirrhosis/

#10 (encephalopath* or fibro* or cirrho*).mp. [mp=title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword, floating subheading]

#11 (#7 or #8 or #9 or #10)

#12 (#3 and #6 and #11)

Science Citation Index Expanded (Web of Science)

From 1900 to date of search.

#4 (#3 AND #2 AND #1)

#3 TS=(encephalopath* or fibro* or cirrho*)

#2 TS=(metronidazol* or elyzol or flagyl* or rozex or zidoval or metro* or protostat or noritate)

#1 TS=(aminoglycoside* or neomycin or neo‐fradin or neo‐tab or mycifradin or myciguent or paromomycin or humatin)